Seqker Biosciences

Personalized cancer vaccines, built on genomics

Seqker Biosciences is advancing personalized cancer immunotherapy through the development of neoantigen vaccines and the computational genomics that power them. Our mission is to make immunotherapy truly personal, designing treatments around the unique biology of each patient's tumor.

Lead program
SQK01Personalized neoantigen cancer vaccine in clinical development
Platform
HeliosAI-driven platform that identifies and designs patient-specific therapies
Focus
Precision oncologyPersonalized cancer vaccines and precision tumor profiling
Partnerships
WorldwideCollaborating with industry partners, research and clinical teams

Our team

Boyang Zhao

Boyang Zhao, PhD

Co-Founder & CEO

Dr. Boyang Zhao leads the company's strategy, its SQK01 neoantigen vaccine program and the development of the Helios computational genomics platform. He brings 15 years of experience in oncology R&D and AI-driven drug discovery. Previously, he has held a number of scientific and leadership roles, including venture-backed healthcare startups, a $4.6B oncology biotech, and an $88B global bank. He holds a PhD from MIT.

Our multidisciplinary team brings together the expertise needed to advance personalized cancer vaccines at every stage of development.

  • Seqker team member
  • Seqker team member
  • Seqker team member
  • Seqker team member
  • Seqker team member
  • Seqker team member
  • Bioinformatics & engineering
  • Preclinical R&D
  • Clinical development
  • Clinical operations
  • Manufacturing
  • Regulatory

Our experience

Our team has trained and worked at leading universities, research institutes, and companies, across oncology, immunology, genomics and drug development.

Previous affiliations

  • MIT
  • Caltech
  • UC Berkeley
  • UCLA
  • UCSF
  • Massachusetts General Hospital
  • NIH
  • Chulalongkorn University
  • Mahidol University
  • Osaka University
  • UCL
  • ARIAD Pharmaceuticals
  • MSD
  • Vir Biotechnology
  • Life Technologies
  • ING

Work with us

Interested in partnering with Seqker, learning more about our technology, or exploring genomic services? We'd welcome the opportunity to connect.

Contact us